Maxim Group Downgrades Intec Pharma Ltd. (NTEC) to Hold Jul 22, 2019 11:13AM
Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares Aug 21, 2017 04:15PM
Intec Pharma (NTEC) Prices 10.6M Share Offering at $4.70/Sh Aug 16, 2017 09:02AM
Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares Aug 16, 2017 09:00AM
Maxim Group Reiterates Buy Rating and $11 PT on Intec Phara (NTEC); 'Ph3 Accordian Study Unfolding as Planned' Mar 30, 2017 10:49AM


Mar 24, 2017 07:35AM Maxim Group Reiterates Buy Rating and $9 PT on Intec Pharma (NTEC) Following Ph1 Trial Initiation of CBD/THC Using the Accordion Delivery System
Sep 7, 2016 03:21PM Intec Pharma to Participate in Upcoming September Conferences
Mar 14, 2016 07:45AM Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
Nov 5, 2015 04:30PM Intec Pharma Reports Results for the Third Quarter of 2015
Sep 17, 2015 05:58PM Intec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares
Sep 15, 2015 05:00PM Maxim Group Starts Intec Pharma Ltd. (NTEC) at Buy
Aug 7, 2015 04:01PM Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering
Aug 4, 2015 10:03AM Intec Pharma (NTEC) IPO Opens Flat
Aug 4, 2015 09:28AM Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share
Aug 4, 2015 09:25AM Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering